[Changes in hemostasis in blood donors on the Fenwal CS 3000 separator].
During thrombocytophereses on a blood cell FENWAL CS 3000 separator in one group of donors the anticoagulant solution ACD-A recommended by the manufacturer was used, in the other group of donors ACD-A with heparin was used. The authors give an account of the changes in some parameters of haemostasis in these donors on the separator incl. examination of fibrinopeptide A which is the most sensitive indicator of clotting activity during separation. Heparin administration prevented a rise of fibrinopeptide A and did not lead to a reduced platelet yield.
Pittrová
H
H
I. interní klinika lékarské fakulty UK, Plzen.
Koza
V
V
Cepelák
V
V
Vít
L
L
D000328:Adult; D000925:Anticoagulants / Q000494:pharmacology; D001782:Blood Donors; D005260:Female; D006487:Hemostasis / Q000187:drug effects; D006801:Humans; D008297:Male; D010983:Plateletpheresis
D000925:Anticoagulants
Sledování zmĕn hemostázy u dárců na separátoru FENWAL CS 3000.